Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 98
Filtrar
1.
Int J Immunopathol Pharmacol ; 34: 2058738420959554, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33084473

RESUMEN

AIM: The present review aimed to consolidate and analyze the recent information about the use of zebrafish in studies concerning cisplatin-induced ototoxicity and otoprotection. MATERIAL AND METHODS: The PubMed, Web of Science, and Scopus databanks were searched using the following MESH terms: zebrafish, cisplatin, ototoxicity. The identified publications were screened according to inclusion and exclusion criteria and the 26 qualifying manuscripts were included in the full-text analysis. The experimental protocols, including cisplatin concentrations, the exposure duration and the outcome measurements used in zebrafish larvae studies, were evaluated and the reported knowledge was summarized. RESULTS: Twenty-six substances protecting from cisplatin-induced toxicity were identified with the use of zebrafish larvae. These substances include quinine, salvianolic acid B, berbamine 6, benzamil, quercetin, dexmedetomidine, dexamethsanone, quinoxaline, edaravone, apocynin, dimethyl sulfoxide, KR-22335, SRT1720, ORC-13661, 3-MA, D-methionine, mdivi-1, FUT-175, rapamycin, Z-LLF-CHO, ATX, NAC, CYM-5478, CHCP1, CHCP2 and leupeptin. The otoprotective effects of compounds were attributed to their anti-ROS, anti-apoptotic and cisplatin uptake-blocking properties. The broadest range of protection was achieved when the experimental flow used preconditioning with an otoprotective compound and later a co-incubation with cisplatin. Protection against a high concentration of cisplatin was observed only in protocols using short exposure times (4 and 6 h). CONCLUSIONS: The data extracted from the selected papers confirm that despite the differences between the human and the zebra fish hearing thresholds (as affected by cisplatin), the sensory cells of zebrafish and larval zebrafish are a valuable tool which could be used: (i) for the discovery of novel otoprotective substances and compounds; (ii) to screen their side effects and (iii) to extend the knowledge on the mechanisms of cisplatin-induced inner ear damage. For future studies, the development of a consensus experimental protocol is highly recommended.


Asunto(s)
Cisplatino , Enfermedades del Oído/prevención & control , Sistema de la Línea Lateral/efectos de los fármacos , Sustancias Protectoras/farmacología , Pez Cebra , Animales , Apoptosis/efectos de los fármacos , Citoprotección , Modelos Animales de Enfermedad , Enfermedades del Oído/inducido químicamente , Enfermedades del Oído/metabolismo , Enfermedades del Oído/patología , Sistema de la Línea Lateral/metabolismo , Sistema de la Línea Lateral/patología , Ototoxicidad , Especies Reactivas de Oxígeno/metabolismo , Especificidad de la Especie , Pez Cebra/embriología
2.
Int J Mol Sci ; 21(17)2020 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-32878208

RESUMEN

Atopic dermatitis (AD) is a complex, often lifelong allergic disease with severe pruritus affecting around 10% of both humans and dogs. To investigate the role of mast cells (MCs) and MC-specific proteases on the immunopathogenesis of AD, a vitamin D3-analog (MC903) was used to induce clinical AD-like symptoms in c-kit-dependent MC-deficient Wsh-/- and the MC protease-deficient mMCP-4-/-, mMCP-6-/-, and CPA3-/- mouse strains. MC903-treatment on the ear lobe increased clinical scores and ear-thickening, along with increased MC and granulocyte infiltration and activity, as well as increased levels of interleukin 33 (IL-33) locally and thymic stromal lymphopoietin (TSLP) both locally and systemically. The MC-deficient Wsh-/- mice showed significantly increased clinical score and ear thickening albeit having lower ear tissue levels of IL-33 and TSLP as well as lower serum levels of TSLP as compared to the WT mice. In contrast, although having significantly increased IL-33 ear tissue levels the chymase-deficient mMCP-4-/- mice showed similar clinical score, ear thickening, and TSLP levels in ear tissue and serum as the WT mice, whereas mMCP-6 and CPA3 -deficient mice showed a slightly reduced ear thickening and granulocyte infiltration. Our results suggest that MCs promote and control the level of MC903-induced AD-like inflammation.


Asunto(s)
Calcitriol/análogos & derivados , Dermatitis Atópica/inmunología , Enfermedades del Oído/prevención & control , Hipersensibilidad/prevención & control , Inflamación/prevención & control , Mastocitos/inmunología , Serina Endopeptidasas/fisiología , Animales , Calcitriol/toxicidad , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/metabolismo , Dermatitis Atópica/patología , Fármacos Dermatológicos/toxicidad , Enfermedades del Oído/etiología , Enfermedades del Oído/metabolismo , Enfermedades del Oído/patología , Femenino , Hipersensibilidad/etiología , Hipersensibilidad/metabolismo , Hipersensibilidad/patología , Inflamación/etiología , Inflamación/metabolismo , Inflamación/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados
3.
Molecules ; 25(6)2020 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-32197377

RESUMEN

In this study, we isolated from the aerial parts of Baccharis conferta Kunth (i) a new neoclerodane, denominated "bacchofertone"; (ii) four known terpenes: schensianol A, bacchofertin, kingidiol and oleanolic acid; and (iii) two flavonoids: cirsimaritin and hispidulin. All structures were identified by an exhaustive analysis of nuclear magnetic resonance (NMR) and mass spectroscopy (MS). Extracts from aerial parts were screened for anti-inflammatory activity in the mice ear edema model of 12-O-tetradecanoylforbol-13-acetate mice. Dichloromethane extract (BcD) exhibited 78.5 ± 0.72% inhibition of edema, followed by the BcD2 and BcD3 fractions of 71.4% and 82.9% respectively, at a dose of 1 mg/ear. Kingidiol and cirsimaritin were the most potent compounds identified, with a median effective dose of 0.12 and 0.16 mg/ear, respectively. A histological analysis showed that the topical application of TPA promoted intense cell infiltration, and this inflammatory parameter was reduced with the topical application of isolated compounds.


Asunto(s)
Antiinflamatorios , Baccharis/química , Enfermedades del Oído , Edema , Flavonas , Terpenos , Acetato de Tetradecanoilforbol/toxicidad , Animales , Antiinflamatorios/química , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/farmacología , Modelos Animales de Enfermedad , Enfermedades del Oído/inducido químicamente , Enfermedades del Oído/tratamiento farmacológico , Enfermedades del Oído/metabolismo , Enfermedades del Oído/patología , Edema/inducido químicamente , Edema/tratamiento farmacológico , Edema/metabolismo , Edema/patología , Flavonas/química , Flavonas/aislamiento & purificación , Flavonas/farmacología , Masculino , Ratones , Ratones Endogámicos ICR , Terpenos/química , Terpenos/aislamiento & purificación , Terpenos/farmacología
4.
Mediators Inflamm ; 2019: 3041438, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31263381

RESUMEN

Despite the usefulness of glucocorticoids, they may cause hazardous side effects that limit their use. Searching for compounds that are as equally efficient as glucocorticoids, but with less side effects, the current study compared plant steroids, namely, glycyrrhetinic acid, guggulsterone, boswellic acid, withaferin A, and diosgenin with the classical glucocorticoid, fluticasone. This was approached both in silico using molecular docking against glucocorticoid receptor (GR) and in vivo in two different animal models. All tested compounds interacted with GR, but only boswellic acid and withaferin A showed docking results comparable to fluticasone, as well as similar in vivo anti-inflammatory effects, by significantly decreasing serum levels of interleukin-6 and tumor necrosis factor-α in cotton pellet-induced granuloma in rats. In addition, both compounds significantly decreased the percent of change in ear weight in croton oil-induced ear edema in mice and the granuloma weight in cotton pellet-induced granuloma in rats, to levels comparable to that of fluticasone. Both boswellic acid and withaferin A had no effect on adrenal index, but only withaferin A significantly increased the thymus index. In conclusion, boswellic acid may have comparable anti-inflammatory effects to fluticasone with fewer side effects.


Asunto(s)
Enfermedades del Oído/tratamiento farmacológico , Enfermedades del Oído/metabolismo , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Fitosteroles/uso terapéutico , Receptores de Glucocorticoides/metabolismo , Animales , Antiinflamatorios/uso terapéutico , Aceite de Crotón/toxicidad , Diosgenina/uso terapéutico , Enfermedades del Oído/sangre , Enfermedades del Oído/inducido químicamente , Edema/sangre , Edema/inducido químicamente , Edema/tratamiento farmacológico , Edema/metabolismo , Ensayo de Inmunoadsorción Enzimática , Ácido Glicirretínico/uso terapéutico , Inflamación/inducido químicamente , Inflamación/inmunología , Interleucina-6/sangre , Ratones , Simulación del Acoplamiento Molecular , Pregnenodionas/uso terapéutico , Ratas , Programas Informáticos , Timo/efectos de los fármacos , Timo/metabolismo , Triterpenos/uso terapéutico , Factor de Necrosis Tumoral alfa/sangre , Witanólidos/uso terapéutico
5.
J Laryngol Otol ; 133(3): 183-186, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30808433

RESUMEN

OBJECTIVE: To investigate the expression of basic fibroblast growth factor in the matrix of human acquired cholesteatoma compared to the deep meatal skin. This topic does not appear to have been fully investigated before. METHODS: An immunochemical study was conducted. Cholesteatoma tissues from adult patients were collected during surgery (n = 19). Control specimens were taken from the deep meatal skin (n = 8) and compared. RESULTS: A highly significant difference in basic fibroblast growth factor expression was identified between cholesteatoma and skin (mean ± standard error = 58.53 ± 3.6 per cent in cholesteatoma vs 40.6 ± 3.5 per cent in skin; p = 0.005). Both basal and parabasal keratinocytes were stained positive with basic fibroblast growth factor. Additionally, there was specific staining in the basal columnar middle-ear epithelium and mast cell membrane. CONCLUSION: Basic fibroblast growth factor plays an active role in proliferative activity of cholesteatoma through its overexpression in basal and parabasal layers of cholesteatoma matrix. Moreover, its expression in the mast cell membrane supports its role in bone resorption activity.


Asunto(s)
Colesteatoma/metabolismo , Enfermedades del Oído/metabolismo , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Colesteatoma del Oído Medio/metabolismo , Conducto Auditivo Externo/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Piel/metabolismo , Adulto Joven
6.
Eur J Med Chem ; 168: 78-86, 2019 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-30798054

RESUMEN

22-Oxocholestanes bearing the oxime functionality in the side chain have been synthesized from diosgenin and evaluated in vivo as anti-inflammatory agents in an acute inflammation mouse ear model, against the commercial glucocorticoid dexamethasone. The final compounds were all regioselectively obtained with an E configuration at the oxime double bond. The title compounds reduced ear-induced inflammation and edema. The most active oximes repressed the expression of proinflammatory genes TNF-α, COX-2, and IL-6; including macrophage migration inhibitory factor. Overall, our data suggest that 22-oxocholestane oximes exert a strong in vivo anti-inflammatory activity.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Colestanos/farmacología , Enfermedades del Oído/tratamiento farmacológico , Edema/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Oximas/farmacología , Animales , Antiinflamatorios no Esteroideos/síntesis química , Antiinflamatorios no Esteroideos/química , Colestanos/síntesis química , Colestanos/química , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Enfermedades del Oído/metabolismo , Edema/metabolismo , Inflamación/metabolismo , Interleucina-6/genética , Interleucina-6/metabolismo , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Masculino , Ratones , Estructura Molecular , Oximas/síntesis química , Oximas/química , Relación Estructura-Actividad , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo
8.
ACS Nano ; 12(8): 7601-7612, 2018 08 28.
Artículo en Inglés | MEDLINE | ID: mdl-30040897

RESUMEN

Hypertrophic scars, characterized by excessive cell proliferation, disordered cell growth, and aberrant deposition of collagens, could cause significant clinical problems. Herein, aligned carbon nanotubes (ACNTs) were synthesized via chemical vapor deposition, and bulk ACNTs were pulled out from the arrays. The capacity of the ACNTs to reduce hypertrophic scar formation was evaluated both in vitro and in vivo. The results demonstrated that the ACNTs suppressed the overproliferation of fibroblast cells, directed their growth, and inhibited collagen expression in vitro without cell cytotoxicity. Moreover, in vivo evaluation in a rabbit ear model indicated relieved scar hypertrophy after the ACNTs treatment. The gene expression microarray was further used to understand the mechanism, which showed that ACNTs could inhibit the TGFß pathway to alter the components in the extracellular matrix, cell proliferation, cell cytoskeleton, and cell motility. These findings may provide a potent strategy of using carbon nanotubes in the bioengineering field.


Asunto(s)
Cicatriz Hipertrófica/tratamiento farmacológico , Enfermedades del Oído/tratamiento farmacológico , Nanotubos de Carbono/química , Animales , Proliferación Celular/efectos de los fármacos , Cicatriz Hipertrófica/metabolismo , Cicatriz Hipertrófica/patología , Modelos Animales de Enfermedad , Enfermedades del Oído/metabolismo , Enfermedades del Oído/patología , Humanos , Ratones , Células 3T3 NIH , Conejos
9.
Otol Neurotol ; 38(10): e501-e505, 2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-29065096

RESUMEN

HYPOTHESIS: There are temporal changes in the outer-hair-cell-specific protein, prestin, in the blood after administration of low-dose cisplatin. METHODS: Two rodent models of ototoxicity were used. After control and baseline data collection, mice (n = 30) and guinea pigs (n = 10), respectively, were treated with cisplatin at 8 mg/kg. Auditory brainstem responses were recorded on Days 1, 3, 7, and 14 after treatment. Five mice were sacrificed at each time point and serum samples were obtained. A group of 10 guinea pigs were tested and serum samples were collected at each time point. Serum prestin concentrations were measured using separate enzyme-linked immunosorbent assays for each species. RESULTS: Auditory brainstem responses thresholds changed relatively little in mice, but gradually increased in guinea pigs, as a function of time after cisplatin exposure. In contrast, serum prestin concentrations rose, reaching a peak on Days 3 and 7 after cisplatin treatment in mouse and guinea pig, respectively, before declining back to or below baseline/control levels 14 days after treatment. CONCLUSION: There was a time-dependent pattern of change in serum prestin after exposure to low-dose cisplatin in a resistant (mouse) and sensitive (guinea pig) rodent models. These comparative results suggest prestin may serve as a biomarker for cisplatin ototoxicity.


Asunto(s)
Antineoplásicos/toxicidad , Cisplatino/toxicidad , Enfermedades del Oído/inducido químicamente , Enfermedades del Oído/metabolismo , Proteínas Motoras Moleculares/sangre , Animales , Umbral Auditivo , Enfermedades del Oído/patología , Potenciales Evocados Auditivos del Tronco Encefálico , Femenino , Cobayas , Células Ciliadas Auditivas Externas/patología , Ratones , Ratones Endogámicos CBA , Especificidad de la Especie
10.
Laryngoscope ; 127(8): E283-E290, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28158903

RESUMEN

OBJECTIVES/HYPOTHESIS: This study investigates the immunohistochemical expression of vascular endothelial growth factor (VEGF) and CD34 in patients treated for middle ear and mastoid cholesterol granulomas to evaluate the angiogenesis and vascularization of this type of lesion. A correlation between the immunohistochemical data and the radiological and intraoperative evidence of temporal bone marrow invasion and blood source connection was performed to validate this hypothesis. STUDY DESIGN: Retrospective study. METHODS: Immunohistochemical expression of VEGF and CD34 in a group of 16 patients surgically treated for cholesterol granuloma was examined. Middle ear cholesteatomas with normal middle ear mucosa and external auditory canal skin were used as the control groups. The radiological and intraoperative features of cholesterol granulomas were also examined. RESULTS: In endothelial cells, there was an increased expression of angiogenetic growth factor receptors in all the cholesterol granulomas in this study. The quantitative analysis of VEGF showed a mean value of 37.5, whereas the CD34 quantitative analysis gave a mean value of 6.8. Seven patients presented radiological or intraoperative evidence of bone marrow invasion, hematopoietic potentialities, or blood source connections that might support the bleeding theory. In all of these cases there was computed tomography or intraoperative evidence of bone erosion of the middle ear and/or temporal bone structures. The mean values of VEGF and CD34 were 41.1 and 7.7, respectively. CONCLUSIONS: High values of VEGF and CD34 are present in patients with cholesterol granulomas. Upregulation of VEGF and CD34 is indicative of a remarkable angiogenesis and a widespread vascular concentration in cholesterol granulomas. LEVEL OF EVIDENCE: 3b. Laryngoscope, 127:E283-E290, 2017.


Asunto(s)
Antígenos CD34/biosíntesis , Enfermedades Óseas/patología , Colesterol , Enfermedades del Oído/patología , Oído Medio/patología , Granuloma de Cuerpo Extraño/patología , Apófisis Mastoides/patología , Neovascularización Patológica/patología , Factor A de Crecimiento Endotelial Vascular/biosíntesis , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antígenos CD34/análisis , Enfermedades Óseas/etiología , Enfermedades Óseas/metabolismo , Enfermedades del Oído/etiología , Enfermedades del Oído/metabolismo , Femenino , Granuloma de Cuerpo Extraño/etiología , Granuloma de Cuerpo Extraño/metabolismo , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Neovascularización Patológica/metabolismo , Estudios Retrospectivos , Factor A de Crecimiento Endotelial Vascular/análisis , Adulto Joven
11.
Sci Signal ; 9(423): eg6, 2016 Apr 12.
Artículo en Inglés | MEDLINE | ID: mdl-27072653

RESUMEN

This Focus Issue highlights new discoveries at the level of the receptor, the α subunit, and the ßγ subunit and spans research in yeast on polarized growth and G protein-coupled receptor (GPCR) trafficking, in mice on an orphan GPCR with constitutive activity, and a disease-causing mutation in an α subunit that results in inappropriate GPCR-G protein coupling.


Asunto(s)
Enfermedades del Oído/genética , Oído/anomalías , Proteínas de Unión al GTP/genética , Mutación , Receptores Acoplados a Proteínas G/genética , Transducción de Señal/genética , Animales , Enfermedades del Oído/metabolismo , Proteínas de Unión al GTP/metabolismo , Humanos , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/crecimiento & desarrollo , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo
12.
Sci Signal ; 9(423): ra37, 2016 Apr 12.
Artículo en Inglés | MEDLINE | ID: mdl-27072656

RESUMEN

Auriculo-condylar syndrome (ACS), a rare condition that impairs craniofacial development, is caused by mutations in a G protein-coupled receptor (GPCR) signaling pathway. In mice, disruption of signaling by the endothelin type A receptor (ET(A)R), which is mediated by the G protein (heterotrimeric guanine nucleotide-binding protein) subunit Gα(q/11) and subsequently phospholipase C (PLC), impairs neural crest cell differentiation that is required for normal craniofacial development. Some ACS patients have mutations inGNAI3, which encodes Gα(i3), but it is unknown whether this G protein has a role within the ET(A)R pathway. We used a Xenopus model of vertebrate development, in vitro biochemistry, and biosensors of G protein activity in mammalian cells to systematically characterize the phenotype and function of all known ACS-associated Gα(i3) mutants. We found that ACS-associated mutations in GNAI3 produce dominant-negative Gα(i3) mutant proteins that couple to ET(A)R but cannot bind and hydrolyze guanosine triphosphate, resulting in the prevention of endothelin-mediated activation of Gα(q/11) and PLC. Thus, ACS is caused by functionally dominant-negative mutations in a heterotrimeric G protein subunit.


Asunto(s)
Enfermedades del Oído/genética , Oído/anomalías , Subunidades alfa de la Proteína de Unión al GTP Gi-Go/genética , Mutación , Transducción de Señal/genética , Secuencia de Aminoácidos , Animales , Enfermedades del Oído/metabolismo , Subunidades alfa de la Proteína de Unión al GTP Gi-Go/metabolismo , Guanosina Trifosfato/metabolismo , Células HEK293 , Humanos , Immunoblotting , Microscopía Fluorescente , Modelos Genéticos , Unión Proteica , Receptor de Endotelina A/genética , Receptor de Endotelina A/metabolismo , Homología de Secuencia de Aminoácido , Técnicas del Sistema de Dos Híbridos , Xenopus laevis
13.
Zhen Ci Yan Jiu ; 40(4): 296-9, 2015 Aug.
Artículo en Chino | MEDLINE | ID: mdl-26502543

RESUMEN

OBJECTIVE: To observe the effect of electroacupuncture (EA) stimulation of "Yifen" (TE 17), "Shenshu" (BL 23) on the expression of 5-hydroxytryptamine receptor 1 B (5-HTR 1 B) mRNA and 5-hydroxytryptamine receptor 2 C (5-HTR 2 C) mRNA in the cochlear nucleus tissue in mice experiencing radiation from mobile phone, so as to explore its mechanisms underlying improvement of tinnitus. METHODS: Thirty Kunming mice were randomly divided into control group (n = 6) and modeling group (n = 24). The tinnitus model was established by giving the mice with mobile phone-radiation for 1 h in the morning and 1 h in the afternoon, continuously for 40 days. EA stimulation was applied to "Yifeng" (TE 17) group (n = 6) and "Shenshu" (BL 23) group (n = 6) for 20 min, once a day for 7 days. The expression of 5-THR 1 B/2 C mRNA in the cochlear nucleus was assayed by fluorescence quantitative polymerase chain reaction (real time-PCR). RESULTS: The expression level of 5-HTR 1 B was significantly lower in the model group than in the control group (P < 0.05), while that of 5-HTR 2 C mRNA significantly increased (P < 0.01). TE 17 group received a significant acupoint intervention effect (P < 0.01). Compared with TE 17 group, BL 23 group received a weaker effect (P < 0.05). CONCLUSION: EA of TE 17 can up-regulate expression level of 5-HTR 1 B and down-regulate expression level of 5-HTR 2 C in the cochlear nucleus in mice experiencing mobile-phone radiation.


Asunto(s)
Teléfono Celular , Cóclea/efectos de la radiación , Enfermedades del Oído/terapia , Electroacupuntura , Ondas de Radio/efectos adversos , Receptor de Serotonina 5-HT1B/genética , Receptor de Serotonina 5-HT2C/genética , Puntos de Acupuntura , Animales , Cóclea/metabolismo , Enfermedades del Oído/etiología , Enfermedades del Oído/genética , Enfermedades del Oído/metabolismo , Femenino , Humanos , Ratones , Receptor de Serotonina 5-HT1B/metabolismo , Receptor de Serotonina 5-HT2C/metabolismo , Serotonina/metabolismo
14.
Mol Neurobiol ; 51(1): 252-67, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24781382

RESUMEN

One of the most unfortunate side effects of aminoglycoside (AG) antibiotics such as neomycin is that they target sensory hair cells (HCs) and can cause permanent hearing impairment. We have observed HC loss and microglia-like cell (MLC) activation in the inner ear (cochlea) following neomycin administration. We focused on CX3CL1, a membrane-bound glycoprotein expressed on neurons and endothelial cells, as a way to understand how the MLCs are activated and the role these cells play in HC loss. CX3CL1 is the exclusive ligand for CX3CR1, which is a chemokine receptor expressed on the surface of macrophages and MLCs. In vitro experiments showed that the expression levels of CX3CL1 and CX3CR1 increased in the cochlea upon neomycin treatment, and CX3CL1 was expressed on HCs, while CX3CR1 was expressed on MLCs. When cultured with 1 µg/mL exogenous CX3CL1, MLCs were activated by CX3CL1, and the cytokine level was increased in the cochleae leading to apoptosis in the HCs. In CX3CR1 knockout mice, a significantly greater number of cochlear HCs survived than in wild-type mice when the cochlear explants were cultured with neomycin in vitro. Furthermore, inhibiting the activation of MLCs with minocycline reduced the neomycin-induced HC loss and improved the hearing function in neomycin-treated mice in vivo. Our results demonstrate that CX3CL1-induced MLC activation plays an important role in the induction of HC death and provide evidence for CX3CL1 and CX3CR1 as promising new therapeutic targets for the prevention of hearing loss.


Asunto(s)
Enfermedades del Oído/inducido químicamente , Enfermedades del Oído/patología , Microglía/patología , Neomicina/efectos adversos , Animales , Anticuerpos Neutralizantes/farmacología , Receptor 1 de Quimiocinas CX3C , Células Cultivadas , Quimiocina CX3CL1/metabolismo , Quimiocina CX3CL1/farmacología , Cóclea/efectos de los fármacos , Cóclea/patología , Enfermedades del Oído/metabolismo , Células Ciliadas Auditivas/efectos de los fármacos , Células Ciliadas Auditivas/metabolismo , Células Ciliadas Auditivas/patología , Pérdida Auditiva/inducido químicamente , Pérdida Auditiva/complicaciones , Pérdida Auditiva/patología , Ratones Endogámicos C57BL , Ratones Noqueados , Microglía/efectos de los fármacos , Minociclina/farmacología , Cadenas Ligeras de Miosina/metabolismo , Neomicina/administración & dosificación , Biosíntesis de Proteínas/efectos de los fármacos , Receptores de Quimiocina/deficiencia , Receptores de Quimiocina/metabolismo , Regulación hacia Arriba/efectos de los fármacos
15.
Biomed Res Int ; 2014: 301294, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24877079

RESUMEN

Cecropia pachystachya is a species traditionally used in Brazil to treat inflammation. This work aims to evaluate the topical anti-inflammatory and antioxidant activities of the methanolic extract of C. pachystachya (CPM) and to perform its chemical fingerprint by HPLC-DAD. The topical anti-inflammatory activity was evaluated using the mouse models of acute ear inflammation induced by croton oil, arachidonic acid, capsaicin, EPP, phenol, and chronic inflammation induced by multiple application of croton oil. The in vitro antioxidant effect of CPM was investigated using DPPH, reducing power, ß -carotene bleaching, and TBARS assays. HPLC analysis was performed to quantify the antioxidant phenolics orientin, isoorientin, and chlorogenic acid previously identified in CPM. CPM exhibited significant anti-inflammatory effect in the acute models, in some cases comparable to the reference drugs. Histopathological analysis showed a moderate chronic skin anti-inflammatory effect with decrease in vasodilation, edema, cell infiltration, and epidermal hyperproliferation. It also showed strong in vitro antioxidant activity. The contents of orientin, isoorientin, and chlorogenic acid were 66.5 ± 1.8, 118.8 ± 0.7, and 5.4 ± 0.2 µg/mg extract, respectively. The topical anti-inflammatory activity of CPM could be based on its antioxidant properties, although other effects are probably involved, including COX inhibition and other mechanisms.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Cecropia/química , Dermatitis/tratamiento farmacológico , Enfermedades del Oído/tratamiento farmacológico , Extractos Vegetales/farmacología , Administración Tópica , Animales , Antiinflamatorios/química , Antioxidantes/química , Dermatitis/metabolismo , Dermatitis/patología , Modelos Animales de Enfermedad , Enfermedades del Oído/inducido químicamente , Enfermedades del Oído/metabolismo , Enfermedades del Oído/patología , Epidermis/metabolismo , Epidermis/patología , Masculino , Ratones , Extractos Vegetales/química
16.
Biomed Res Int ; 2014: 121098, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24795877

RESUMEN

nAG (newt-Anterrior Gradient) protein is the key mediator of regrowth of amputated limbs in salamanders. In a previous work in our lab, a new nAG gene (suitable for humans) was designed and cloned. The cloned vector was transfected into primary human fibroblasts. The expression of nAG in human primary fibroblasts was found to suppress collagen expression. The current study shows that local injection of recombinant nAG reduces scar hypertrophy in the rabbit ear model. This is associated with lower scar elevation index (SEI), lower levels of collagen I & III, higher levels of MMP1, and a higher degree of scar maturation in experimental wounds compared to controls.


Asunto(s)
Proteínas Anfibias/administración & dosificación , Productos Biológicos/administración & dosificación , Cicatriz Hipertrófica/tratamiento farmacológico , Cicatriz Hipertrófica/patología , Enfermedades del Oído/tratamiento farmacológico , Enfermedades del Oído/patología , Urodelos/metabolismo , Proteínas Anfibias/genética , Animales , Colágeno/metabolismo , Enfermedades del Oído/metabolismo , Inyecciones Intralesiones , Conejos , Proteínas Recombinantes/administración & dosificación , Resultado del Tratamiento , Urodelos/genética , Cicatrización de Heridas/efectos de los fármacos
17.
Am J Hum Genet ; 93(6): 1118-25, 2013 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-24268655

RESUMEN

Auriculocondylar syndrome (ACS) is a rare craniofacial disorder with mandibular hypoplasia and question-mark ears (QMEs) as major features. QMEs, consisting of a specific defect at the lobe-helix junction, can also occur as an isolated anomaly. Studies in animal models have indicated the essential role of endothelin 1 (EDN1) signaling through the endothelin receptor type A (EDNRA) in patterning the mandibular portion of the first pharyngeal arch. Mutations in the genes coding for phospholipase C, beta 4 (PLCB4) and guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 (GNAI3), predicted to function as signal transducers downstream of EDNRA, have recently been reported in ACS. By whole-exome sequencing (WES), we identified a homozygous substitution in a furin cleavage site of the EDN1 proprotein in ACS-affected siblings born to consanguineous parents. WES of two cases with vertical transmission of isolated QMEs revealed a stop mutation in EDN1 in one family and a missense substitution of a highly conserved residue in the mature EDN1 peptide in the other. Targeted sequencing of EDN1 in an ACS individual with related parents identified a fourth, homozygous mutation falling close to the site of cleavage by endothelin-converting enzyme. The different modes of inheritance suggest that the degree of residual EDN1 activity differs depending on the mutation. These findings provide further support for the hypothesis that ACS and QMEs are uniquely caused by disruption of the EDN1-EDNRA signaling pathway.


Asunto(s)
Enfermedades del Oído/genética , Oído/anomalías , Genes Dominantes , Genes Recesivos , Mutación , Fenotipo , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Análisis Mutacional de ADN , Enfermedades del Oído/diagnóstico , Enfermedades del Oído/metabolismo , Endotelina-1/genética , Endotelina-1/metabolismo , Femenino , Genotipo , Humanos , Masculino , Datos de Secuencia Molecular , Linaje , Alineación de Secuencia , Transducción de Señal
18.
Cell Mol Life Sci ; 70(21): 4141-55, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23588489

RESUMEN

Genomes are transcribed well beyond the conventionally annotated protein-encoding genes and produce many thousands of regulatory non-coding RNAs (ncRNAs). In the last few years, ncRNAs, especially microRNAs and long non-coding RNA, have received increasing attention because of their implication in the function of chromatin-modifying complexes and in the regulation of transcriptional and post-transcriptional events. The morphological events and the genetic networks responsible for the development of sensory organs have been well delineated and therefore sensory organs have provided a useful scenario to address the role of ncRNAs. In this review, we summarize the current information on the importance of microRNAs and long non-coding RNAs during the development of the eye, inner ear, and olfactory system in vertebrates. We will also discuss those cases in which alteration of ncRNA expression has been linked to pathological conditions affecting these organs.


Asunto(s)
Oído Interno/embriología , Ojo/embriología , Vías Olfatorias/embriología , ARN no Traducido/metabolismo , Animales , Linaje de la Célula , Proliferación Celular , Cromatina/metabolismo , Enfermedades del Oído/genética , Enfermedades del Oído/metabolismo , Oftalmopatías/genética , Oftalmopatías/metabolismo , Perfilación de la Expresión Génica , Regulación del Desarrollo de la Expresión Génica , Genoma , Humanos , Fenotipo , Factores de Tiempo
19.
J Proteomics ; 83: 119-29, 2013 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-23517718

RESUMEN

Human cerumen, also called earwax, is a substance secreted by various glands in the outer ear canal. Although the variation of texture and color during otorhinolaryngological diseases is a generally known phenomenon, cerumen as biofluid remains relatively unexplored. However, there is an emerging interest for protein biomarkers which are easily accessible and predictive for diagnostics and therapy outcome. Here we provide a thorough investigation of human cerumen applying two different prefractionation techniques: i) 1D-PAGE prefractionation with subsequent LC-MS/MS, and ii) online SCX-fractionation coupled to LC-MS/MS. Additionally, individual variation was addressed by shotgun LC-MS/MS of specimens from 5 subjects. In total, we identified 11,562 distinct peptides representing 2013 proteins in human cerumen. The in-depth characterization revealed a high complexity of cerumen comparable with other human biofluids such as urine, plasma, or saliva. A probiotic or antibiotic character of cerumen has previously been discussed. In this study we provide further evidence for the important role of cerumen as an antimicrobial barrier and in local immune response, e.g. by assessing high amounts of zinc-alpha-2-glycoprotein. PRACTICAL IMPLICATIONS: Cerumen analysis might have promising potential as diagnostic body fluid for biomarker characterization and disease specific objectives. Disease-associated or infection-specific changes may support diagnostics in otorhinolaryngology and may lead to a better understanding of human cerumen's function in immune response. An easy-to-handle and standardized sample collection and preparation of cerumen can further improve individualized medicine strategies.


Asunto(s)
Cerumen/metabolismo , Proteoma/metabolismo , Proteómica/métodos , Adulto , Biomarcadores/metabolismo , Enfermedades del Oído/diagnóstico , Enfermedades del Oído/metabolismo , Femenino , Humanos , Masculino
20.
Ear Nose Throat J ; 91(9): 364, 366, 368, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22996708

RESUMEN

Juvenile xanthogranuloma (JXG) is a benign, non-Langerhans cell histiocytic lesion that generally affects infants and children. These lesions characteristically appear as a solitary, yellow, cutaneous nodule of the head, neck, or trunk. Subcutaneous and extracutaneous forms can involve the gastrointestinal tract, kidney, lung, gonads, pericardium, central nervous system, temporal bone, larynx, and eye. We describe the clinical presentation, imaging, histochemical findings, and management of a solitary JXG of the tympanic membrane in a 17-month-old girl. The patient underwent surgical resection and was without disease several months following surgery and reconstruction of the defect. To the best of our knowledge, this is the first reported case of a JXG of the tympanic membrane.


Asunto(s)
Enfermedades del Oído/patología , Membrana Timpánica/patología , Xantogranuloma Juvenil/patología , Antígenos CD/metabolismo , Antígenos CD1/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Enfermedades del Oído/metabolismo , Enfermedades del Oído/cirugía , Femenino , Humanos , Inmunohistoquímica , Lactante , Membrana Timpánica/metabolismo , Membrana Timpánica/cirugía , Xantogranuloma Juvenil/metabolismo , Xantogranuloma Juvenil/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA